Skip to main content
logo
Aequus Pharmaceuticals Inc. (AQSZF)
OTCMKTS · Delayed Price · Currency is USD
0.0035
0.00 (0.00%)
At close: Jun 24, 2025

Aequus Pharmaceuticals Revenue

Aequus Pharmaceuticals had revenue of 226.55K CAD in the quarter ending March 31, 2025, with 331.06% growth. This brings the company's revenue in the last twelve months to 758.23K, up 252.34% year-over-year. In the year 2024, Aequus Pharmaceuticals had annual revenue of 584.24K with 129.21% growth.

Revenue (ttm)
758.23K CAD
Revenue Growth
+252.34%
P/S Ratio
0.91
Revenue / Employee
n/a
Employees
n/a
Market Cap
478.54K USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024584.24K329.34K129.21%
Dec 31, 2023254.90K-1.12M-81.53%
Dec 31, 20221.38M-1.33M-49.17%
Dec 31, 20212.71M122.09K4.71%
Dec 31, 20202.59M960.09K58.81%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Tian'an Technology Group 1.78M
Glass House Brands 215.62M
American Oncology Network 1.76B
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

Aequus Pharmaceuticals News

More News